Tian et al30 identified that the cervical cancer patients with five notable nonsynonymous mutant genes (PIK3CA, BRAF, GNA11, FBXW7, and CDH1) metastatic relapse significantly mutated mutations had significantly poor DFS and OS. The gene discussed is BRAF; the disease is cervical cancer.